Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis Research Letter

  

Authors:	Rosenbaum, C. A.; Özbek, U.; Sanchez, L.; Lagdameo, J.; Abrahams, A.; Hassoun, H.; Lahoud, O.; Niesvizky, R.; Landau, H. J.; Osman, K.
Title:	Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis
Journal Title:	Blood Advances
Volume:	6
Issue:	18
ISSN:	2473-9529
Publisher:	American Society of Hematology
Date Published:	2022-09-27
Start Page:	5436
End Page:	5439
Language:	English
DOI:	10.1182/bloodadvances.2022007826
PUBMED:	35858371
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85139433950&doi=10.1182%2fbloodadvances.2022007826&partnerID=40&md5=5800902c16fb0985a9798c1e767a7683
Notes:	Letter -- Export Date: 1 November 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/199066